ObesityWeek

ObesityWeek

Source: Healio interview
Disclosures: Kashyap reports serving on advisory boards for Fractyl Health and GI dynamics, and as chief medical officer for Gila Therapeutics. Kumar reports consulting for Eli Lilly and Gelesis and serving on the speakers bureau for Novo Nordisk.
November 02, 2021
1 min watch
Save

VIDEO: Obesity increases risks for long-term COVID-19 symptoms

Source: Healio interview
Disclosures: Kashyap reports serving on advisory boards for Fractyl Health and GI dynamics, and as chief medical officer for Gila Therapeutics. Kumar reports consulting for Eli Lilly and Gelesis and serving on the speakers bureau for Novo Nordisk.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this video exclusive, Healio | Endocrine Today Co-editor Sangeeta R. Kashyap, MD, talks with Rekha Kumar, MD, about special considerations with COVID-19 for people with obesity.

Kashyap is a physician scientist in the Endocrinology Institute at Cleveland Clinic and professor of medicine at the Cleveland Clinic Lerner College of Medicine. Kumar is an endocrinologist and obesity medicine specialist at Weill Cornell Medicine and former medical director of the American Board of Obesity Medicine.

People with obesity who become ill with COVID-19 are at higher risk for severe disease and for long-haul symptoms, Kumar said. She recommended COVID-19 testing and vaccination for people with obesity and increased attention to any symptoms for those exposed to the virus. She noted that weight stigma may lead patients with obesity to present later in the disease course than those without weight concerns.